Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00002398 · ClinicalTrials.gov registry record · NA
Safety and Effectiveness of Giving Adefovir (Preveon) Plus Other Anti-HIV Drugs to HIV-Infected Patients Who Have Not Responded to Other Anti-HIV Drug Combinations
A NA study, sponsored by Gilead Sciences.
- Completed
- Registry status
- NA
- Development phase
NCT00002398 is a NA study that has completed, run by Gilead Sciences.
The verdict
NCT00002398, a NA study, has completed, sponsored by Gilead Sciences.
- COMPLETED
- Registry status
- NA
- Development phase
Study Summary
The purpose of this study is to see if it is safe and effective to give adefovir plus other anti-HIV drugs to HIV-infected patients who have failed other anti-HIV drug combinations. This study will try to make adefovir available to all AIDS patients who need it. Some patients do not respond to anti-HIV drug combinations, even when different combinations are tried. Adefovir may be able to help these patients fight HIV.
Interventions
- DRUG Levocarnitine
- DRUG Adefovir dipivoxil
Trial Details
| Field | Value |
|---|---|
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00002398
The ClinicalTrials.gov registry entry for NCT00002398 describes a study currently listed as completed, categorized as NA. An enrollment target was not published in the registry record, which is common for early-stage or observational entries. The listed sponsor is Gilead Sciences, which has 504 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Levocarnitine is the first listed.
NCT00002398 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00002398 about?
NCT00002398 is a clinical study titled "Safety and Effectiveness of Giving Adefovir (Preveon) Plus Other Anti-HIV Drugs to HIV-Infected Patients Who Have Not Responded to Other Anti-HIV Drug Combinations". The purpose of this study is to see if it is safe and effective to give adefovir plus other anti-HIV drugs to HIV-infected patients who have failed other anti-HIV drug combinations. This study will try to make adefovir available to all AIDS patients who need it. Some patients do not respond to anti...
What is the current status of trial NCT00002398?
This trial is currently completed. It is a NA study.
What interventions are being tested in trial NCT00002398?
The interventions under investigation include: Levocarnitine (DRUG), Adefovir dipivoxil (DRUG).
Who is sponsoring clinical trial NCT00002398?
This trial is sponsored by Gilead Sciences, which has 504 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.